A股午評:創業板指漲超3%,軟件、醫藥股大面積漲停,兩市超4300股上漲
格隆匯10月26日丨一行兩會一局齊發聲維護股、債、樓市健康發展,滬深兩市高開高走,截止午間收盤,滬指漲1.4%報3018點,深成指漲2.3%,科創50、創業板指漲超3%。兩市4357股上漲,540股下跌,成交額5740億,北上資金淨買入60.5億。

題材概念整體表現強勁,軟件股大面積漲停,信創、數字貨幣、信息安全、操作系統等相關題材漲幅居前,競業達再度封板漲停;醫藥股同樣現漲停潮,新冠藥、CXO、疫苗等相關題材強勁;發改委等部門提“便利國際商務人員往來”,旅遊、酒店餐飲板塊再度走強;元器件、造紙、半導體板塊等板塊大漲靠前。

日用化工板塊暴漲,貝泰妮漲約12%、珀萊雅漲8%、上海家化漲近7%。上海家化2022年第三季度營收16.39億元,同比增長1.17%;實現淨利潤1.56億元,同比上升15.55%。貝泰妮三季度實現營收8.46億元,同比增長20.65%,實現歸母淨利潤1.22億元,同比增長35.49%。

軟件股大面積漲停,信創、智慧政務、信息安全等概念大漲靠前,誠邁科技20釐米漲停,創業慧康、潤和軟件、衞寧健康、創意信息等多股漲幅在10%以上,衞士通、中國軟件等16股漲停;昨日再發異動公吿的競業達封板漲停,股價續創歷史新高,9月28日至今累計上漲246%。

醫藥股現漲停潮,CXO、新冠藥、新冠檢測、疫苗等相關題材全線大漲,康希諾、三諾生物、藥石科技20CM漲停,康龍化成、康泰生物、泰格醫藥、普利製藥等多股漲幅在10%以上,凱萊英、通化金馬、仁和藥業等17股漲停,藥明康德、智飛生物漲超8%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.